Diabetes Technology & Therapeutics

Diabetes Technology & Therapeutics Journal

Publication venue for

REAL-WORLD EVIDENCE DEMONSTRATES COMPARABLE CLINICAL OUTCOMES OF SWITCHING FROM INSULIN GLARGINE 100 U/ML TO INSULIN GLARGINE 300 U/ML VS INSULIN DEGLUDEC IN T2D PATIENTS. 20:A137-A138. 2018

International Standard Serial Number (ISSN)

1520-9156